Table 3.
Predictive performance of various models to assess progression-free survival.
| Brier score | 95%CI | AUC | 95%CI | ||
|---|---|---|---|---|---|
| Clinical Model | Training | 0.27 | (0.237-0.286) | 0.85 | (0.789-0.909) |
| Test | 0.21 | (0.181-0.239) | 0.82 | (0.647-0.964) | |
| Radiomics Signature | Training | 0.24 | (0.208-0.259) | 0.87 | (0.814-0.912) |
| Test | 0.26 | (0.215-0.292) | 0.77 | (0.589-0.896) | |
| Radiomics Nomogram | Training | 0.24 | (0.212-0.266) | 0.91 | (0.858-0.943) |
| Test | 0.22 | (0.177-0.255) | 0.87 | (0.733-0.968) | |